Chatterji; Ashish

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chatterji; Ashish.The latest application filed is for "pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists".

Company Profile

8.8.25

Chatterji; Ashish - East Brunswick NJ
Chatterji; Ashish - Bridgewater NJ
Chatterji; Ashish - New Brunswick NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists App 20220241260 - Chatterji; Ashish ; et al.	2022-08-04
Gastroretentive Dosage Forms For Sustained Drug Delivery App 20220218604 - Meghpara; Kanji ; et al.	2022-07-14
Gastroretentive dosage forms for sustained drug delivery Grant 11,318,091 - Meghpara , et al. May 3, 2	2022-05-03
Gastroretentive Dosage Forms For Sustained Drug Delivery App 20210236421 - Meghpara; Kanji ; et al.	2021-08-05
Gastroretentive dosage forms for sustained drug delivery Grant 11,007,145 - Meghpara , et al. May 18, 2	2021-05-18
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists App 20210052567 - Chatterji; Ashish ; et al.	2021-02-25
Gastroretentive dosage forms for sustained drug delivery Grant 10,918,597 - Meghpara , et al. February 16, 2	2021-02-16
Gastroretentive Dosage Forms For Sustained Drug Delivery App 20210022999 - Meghpara; Kanji ; et al.	2021-01-28
Gastroretentive dosage forms for sustained drug delivery Grant 10,857,098 - Meghpara , et al. December 8, 2	2020-12-08
Gastroretentive Dosage Forms For Sustained Drug Delivery App 20200337998 - Meghpara; Kanji ; et al.	2020-10-29
Gastroretentive Dosage Forms For Sustained Drug Delivery App 20200261359 - Meghpara; Kanji ; et al.	2020-08-20
Abuse-resistant drug formulations Grant 10,744,131 - Sandhu , et al. A	2020-08-18
Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient Grant 10,695,296 - Shah , et al.	2020-06-30
Abuse-resistant drug formulations with built-in overdose protection Grant 10,632,113 - Vaka , et al.	2020-04-28
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists App 20190216789 - Chatterji; Ashish ; et al.	2019-07-18
Formulations, Methods, Kit, And Dosage Forms For Improved Stability Of An Active Pharmaceutical Ingredient App 20190015337 - Shah; Navnit ; et al.	2019-01-17
Enhanced Abuse-deterrent Formulations Of Oxycodone App 20180303757 - Banerjee; Siddhartha ; et al.	2018-10-25
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (mglu5) Antagonists App 20170202819 - Chatterji; Ashish ; et al.	2017-07-20
Abuse-resistant Drug Formulations With Built-in Overdose Protection App 20160346274 - Vaka; Siva Ram Kiran ; et al.	2016-12-01
Abuse-resistant Drug Formulations App 20160317530 - Sandhu; Harpreet Kaur ; et al.	2016-11-03
Pharmaceutical Composition And Process App 20150209294 - Chatterji; Ashish ; et al.	2015-07-30
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists App 20150140087 - Chatterji; Ashish ; et al.	2015-05-21
Pharmaceutical Composition With Improved Bioavailability, Safety And Tolerability App 20140128431 - Anand; Shalini M. ; et al.	2014-05-08
Process For Controlled Crystallization Of An Active Pharmaceutical Ingredient From Supercooled Liquid State By Hot Melt Extrusion App 20120213827 - Chatterji; Ashish ; et al.	2012-08-23
Pharmaceutical compositions with superior product performance and patient compliance Grant 8,222,230 - Chatterji , et al. July 17, 2	2012-07-17
Pharmaceutical Compositions For Poorly Soluble Drugs App 20120129898 - Chatterji; Ashish ; et al.	2012-05-24
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (mglu5) Antagonists App 20120039999 - Chatterji; Ashish ; et al.	2012-02-16
Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (mglu5) Antagonists App 20120040008 - Chatterji; Ashish ; et al.	2012-02-16
Pharmaceutical Compositions For Poorly Soluble Drugs App 20110245305 - Chatterji; Ashish ; et al.	2011-10-06
Pharmaceutical Compositions For Poorly Soluble Drugs App 20110028524 - Chatterji; Ashish ; et al.	2011-02-03
Pharmaceutical Compositions With Superior Product Performance And Patient Compliance App 20100184716 - Chatterji; Ashish ; et al.	2010-07-22
Pharmaceutical Compositions For Poorly Soluble Drugs App 20080293787 - Chatterji; Ashish ; et al.	2008-11-27
Pharmaceutical composition and process App 20070184113 - Chatterji; Ashish ; et al.	2007-08-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.